Skip to main content
SpringerLink
Log in

Plasma and Red Blood Cell Fatty Acids in Peroxisomal Disorders

  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

The demonstration of abnormal levels of fatty acids or plasmalogens in plasma or red blood cells is key to the diagnosis of peroxisomal disorders. We report the levels of 62 fatty acids and plasmalogens in patients with X-linked adrenoleukodystrophy (X-ALD), Zellweger syndrome (ZS), neonatal adrenoleukodystrophy (NALD), and infantile Refsum disease (IRD), both at baseline and after dietary interventions. “Lorenzo's Oil” therapy in X-ALD normalizes the levels of saturated very long chain fatty acids in plasma, but leads to reduced levels of omega 6 and other omega 3 fatty acids, and requires monitoring and appropriate dietary supplements. Patients with ZS, NALD and IRD have reduced levels of docosahexaenoic acid (DHA) and arachidonic acid (AA) which can be normalized by the oral administration of microencapsulated DHA and AA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Igarashi, M., Schaumburg, H. H., Powers, J., Kishimoto, Y., Kolodny, E., and Suzuki, K. 1976: Fatty acid abnormality in adrenoleukodystrophy. J. Neurochem. 26:851–860.

    PubMed  Google Scholar 

  2. Mosser, J., Lutz, Y., Stoeckel, M. E., Sarde, C.-O., Kretz, C., Douar, A. M., Lopez, J., Aubourg, P., and Mandel, J. L. 1994. The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. Hum. Mol. Genet. 3(2):265–271.

    PubMed  Google Scholar 

  3. Moser, H. W. 1997. Adrenoleukodystrophy: Phenotype, genetics, pathogenesis and therapy. Brain. 120:1485–1508.

    PubMed  Google Scholar 

  4. Singh, I., Moser, A. B., Goldfischer, S., and Moser, H. W. 1984. Lignoceric acid is oxidized in the peroxisomes: Implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy. Proc. Natl. Acad. Sci. USA. 81:4203–4207.

    PubMed  Google Scholar 

  5. Moser, A. B., Singh, I., Brown III, F. R., Solish, G. I., Kelly, R. I., Benke, P. J., and Moser, H. W. 1984. The cerebro-hepato-renal (Zellweger) syndrome: Increased levels and impaired degradation of very long chain fatty acids, and prenatal diagnosis. New Engl. J. Med. 310:1141–1145.

    PubMed  Google Scholar 

  6. Wanders, R. J. A., Barth, P. G., Schutgens, R. B. H., and Heymans, H. S. 1996. A. Peroxisomal disorders: Post-and prenatal diagnosis based on a new classification with flowcharts. Int. Pediatr. 11(4):203–214.

    Google Scholar 

  7. Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-M., and Aubourg, P. 1993. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature. 361:726–730.

    PubMed  Google Scholar 

  8. Martinez, M. 1989. Polyunsaturated fatty acid changes suggesting a new enzymatic defect in Zellweger syndrome. Lipids. 24:261–265.

    PubMed  Google Scholar 

  9. Bazan, N. G. 1990. Supply of n-3 polyunsaturated fatty acids and their significance in the central nervous system. In: Wurtman, R. J. and Wurtman, J. J. (Ed). Nutrition and the Brain. New York: Raven Press; Volume 8 pp. 1–22.

    Google Scholar 

  10. Zellweger, H. 1987. The cerebro-hepato-renal (Zellweger) syndrome and other peroxisomal disorders. Dev. Med. Child. Neurol. 29:821–829.

    PubMed  Google Scholar 

  11. Braverman, N., Dodt, G., Gould, S. J., and Valle, D. 1995. Disorders of peroxisome biogenesis. Hum. Mol. Genet. 4:1791–1798.

    PubMed  Google Scholar 

  12. Moore, S. A., Hurt, E., Yoder, E., Sprecher, H., and Spector, A. A. 1995. Docosahexaenoic acid synthesis in human skin fibroblasts involves peroxisomal retroconversion of tetracosahexaenoic acid. J. Lipid. Res. 36:2433–2443.

    PubMed  Google Scholar 

  13. Ho, J. K., Moser, H., Kishimoto, Y., and Hamilton, J. A. 1995. Interaction of very long chain fatty acid with model membranes and serum albumin: Implications for the pathogenesis of adrenoleukodystrophy. J. Clin. Invest. 96:1455–1463.

    PubMed  Google Scholar 

  14. Whitcomb, R. W., Linehan, W. R., and Knazek, R. A. 1988. Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro. J. Clin. Invest. 81:185–188.

    PubMed  Google Scholar 

  15. Martinez, M. 1993. Abnormal profiles of polyunsaturated fatty acids in the brain, liver, kidney, and retina of patients with peroxisomal disorders. Brain Res. 583:171–182.

    Google Scholar 

  16. Martinez, M., Pineda, M., Vidal, R., and Martin, B. 1993. Docosahexaenoic acid: A new therapeutic approach to peroxisomal patients. Experience with two cases. Neurology. 43:1389–1397.

    PubMed  Google Scholar 

  17. Rizzo, W. B., Leshner, R. T., Odone, A., Dammann, A. L., Craft, D. A., Jensone, M. E., Jennings, S. S., Davis, S., Jaitly, R., and Sgro, J. A. 1989. Dietary erucic acid therapy for X-linked adrenoleukodystrophy. Neurology. 39(11):1415–1422.

    PubMed  Google Scholar 

  18. Odone, A. and Odone M. Lorenzo's oil. 1989. A new treatment for adrenoleukodystrophy. J. Pediatr. Neurosci. 5:55–61.

    Google Scholar 

  19. Martinez, M. 1990. Severe deficiency of docosahexaenoic acid in peroxisomal disorders: A defect of delta-4 desaturations? Neurology. 40:1292–1298.

    PubMed  Google Scholar 

  20. Lepage, G. and Roy, C. C. 1986. Direct transesterification of all classes of lipids in a one-step reaction. J. Lipid Res. 27:114–120.

    PubMed  Google Scholar 

  21. Martinez, M., Mougan, I., Roig, M., and Ballabriga, A. 1994. Blood polyunsaturated fatty acids in patients with peroxisomal disorders. A multicenter study. Lipids. 29:273–280.

    PubMed  Google Scholar 

  22. Moser, A. B., Rasmussen, M., Naidu, S., Watkins, P. A., McGuinness, M., Hajra, A. K., Chen, G., Raymond, G., Liu, A., Gordon, D., Garnaas, K., Walton, D. S., Skjeldal, O. H., Guggenheim, M. A., Jackson, L. G., Elias, E. R., and Moser, H. W. 1995. Phenotype of patients with peroxisomal disorders subdivided into 16 complementation groups. J. Pediatr. 127:13–22.

    PubMed  Google Scholar 

  23. Moser, H. W. and Borel, J. 1995. Dietary therapy for adrenoleukodystrophy. Annu. Rev. Nutr. 15:379–397.

    PubMed  Google Scholar 

  24. Lepage, G., Levy, E., Ronco, N., Smith, L., Galeano, N., and Roy, C. C. 1989. Direct transesterification of plasma fatty acids for the diagnosis of essential fatty acid deficiency in cystic fibrosis. J. Lipid. Res. 30:1484–1490.

    Google Scholar 

  25. Moser, H. W., Smith, K. D., and Moser, A. B. 1994. X-linked Adrenoleukodystrophy. Pages 2325–2349; in Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D. (eds). The Metabolic and Molecular Basis of Inherited Disease. Seventh Edition. New York: McGraw Hill; (Chapter 72).

    Google Scholar 

  26. Holman, R. T. 1960. The ratio of trienoic-tetranoic acids in tissue lipids as a measure of essential fatty acid requirement. J. Nutr. 70:405.

    PubMed  Google Scholar 

  27. Decsi, T. and Koletsko, B. 1994. Fatty acid composition of plasma lipid classes in healthy subjects from birth to young adulthood. Eur. J. Pediatr. 153:520–525.

    PubMed  Google Scholar 

  28. Innis, S. M. 1991. Essential fatty acids in growth and development. Prog. Lipid. Res. 30(1):39–103.

    PubMed  Google Scholar 

  29. Moser, H. W. and Moser, A. B. 1996. Very long chain fatty acids in diagnosis, pathogenesis, and therapy of peroxisomal disorders. Lipids. 31(Suppl):S141–S145.

    PubMed  Google Scholar 

  30. Avoldano, M. I. and Donnari, D. 1996. Plasma phospholipid fatty acids in X-linked adrenoleukodystrophy. Clin. Chem. 42:454–461.

    PubMed  Google Scholar 

  31. Martinez, M. 1992. Treatment with docosahexaenoic acid favorably modifies the fatty acid composition of erythrocytes in peroxisomal patients. In: Coates, P. M. and Tanaka, K. (Eds). Proceedings of the Second International Symposium on Clinical, Biochemical, and Molecular Aspects of Fatty Acid Oxidation. New York: Wiley-Liss; pp. 389–397.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurogenetics Research Unit, Kennedy Krieger Institute and Departments of Neurology and Pediatrics Johns Hopkins University, USA

    Ann B. Moser, David S. Jones, Gerald V. Raymond & Hugo W. Moser

Authors
  1. Ann B. Moser
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David S. Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gerald V. Raymond
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hugo W. Moser
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moser, A.B., Jones, D.S., Raymond, G.V. et al. Plasma and Red Blood Cell Fatty Acids in Peroxisomal Disorders. Neurochem Res 24, 187–197 (1999). https://doi.org/10.1023/A:1022549618333

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022549618333

Search

Navigation